Showing results (101-110 of 359) with videos related to
Sort By:
Pageof 36
Expert Review of Clinical Pharmacology|August 30, 2019
Tagraxofusp, the first CD123-targeted therapy and first targeted treatment for blastic plasmacytoid dendritic cell neoplasmMinas P Economides, Deborah McCue, Andrew A Lane, et al.Current Hematologic Malignancy Reports|August 6, 2016
Social Media and Internet Resources for Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)Naveen Pemmaraju, Vikas Gupta, Michael A Thompson, et al.Stem Cell Reports|July 26, 2016
Distinctive Mesenchymal-Parenchymal Cell Pairings Govern B Cell Differentiation in the Bone MarrowVionnie W C Yu, Stefania Lymperi, Toshihiko Oki, et al.The Journal of Clinical Investigation|March 2, 2016
Endogenous transmembrane protein UT2 inhibits pSTAT3 and suppresses hematological malignancyDongjun Lee, Ying-Hua Wang, Demetrios Kalaitzidis, et al.Cell Stem Cell|March 29, 2008
Wnt signaling in the niche enforces hematopoietic stem cell quiescence and is necessary to preserve self-renewal in vivoHeather E Fleming, Viktor Janzen, Cristina Lo Celso, et al.Cell Reports|February 5, 2013
SIRT3 reverses aging-associated degenerationKatharine Brown, Stephanie Xie, Xiaolei Qiu, et al.Current Protocols in Cytometry|October 19, 2018
Cell Cycle Analysis of Hematopoietic Stem and Progenitor Cells by Multicolor Flow CytometryAmy Galvin, Meredith Weglarz, Kat Folz-Donahue, et al.American Journal of Clinical Pathology|March 7, 2023
Expanding the Immunophenotypic Spectrum of Neoplastic and Reactive Plasmacytoid Dendritic CellsSarah J Wu, Sam Sadigh, Andrew A Lane, et al.Haematologica|August 5, 2005
Murine acute promyelocytic leukemia cells can be recognized and cleared in vivo by adaptive immune mechanismsJessica L Pollock, Andrew A Lane, Kelly Schrimpf, et al.Cell|June 29, 2023
Loss of chromosome Y in primary tumorsMeifang Qi, Jiali Pang, Irene Mitsiades, et al.Pageof 36